King completes Meridian acquisition:
This article was originally published in Clinica
Executive Summary
King Pharmaceuticals has completed its cash acquisition of Meridian Medical Technologies for $247.8m. It was attracted by the Columbia, Maryland-based firm's auto-injector technology as well as the drugs - including an antidote to nerve gas and epinephrine for emergency treatment of anaphylactic shock - they contain (see Clinica No 1030, p 13).